218 related articles for article (PubMed ID: 31315441)
21. An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.
Arzamendi D; Dandachli F; Théorêt JF; Ducrocq G; Chan M; Mourad W; Gilbert JC; Schaub RG; Tanguay JF; Merhi Y
Clin Appl Thromb Hemost; 2011; 17(6):E70-8. PubMed ID: 21078615
[TBL] [Abstract][Full Text] [Related]
22. The von Willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy: a randomized trial.
Markus HS; McCollum C; Imray C; Goulder MA; Gilbert J; King A
Stroke; 2011 Aug; 42(8):2149-53. PubMed ID: 21700934
[TBL] [Abstract][Full Text] [Related]
23. Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia.
Rauch A; Dupont A; Rosa M; Desvages M; Le Tanno C; Abdoul J; Didelot M; Ung A; Ruez R; Jeanpierre E; Daniel M; Corseaux D; Spillemaeker H; Labreuche J; Pradines B; Rousse N; Lenting PJ; Moussa MD; Vincentelli A; Bordet JC; Staels B; Vincent F; Denis CV; Van Belle E; Casari C; Susen S
Circ Res; 2023 Oct; 133(10):826-841. PubMed ID: 37883587
[TBL] [Abstract][Full Text] [Related]
24. Targeting von Willebrand factor and platelet glycoprotein Ib receptor.
Firbas C; Siller-Matula JM; Jilma B
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1689-701. PubMed ID: 21108551
[TBL] [Abstract][Full Text] [Related]
25. Humanized GPIbα-von Willebrand factor interaction in the mouse.
Kanaji S; Orje JN; Kanaji T; Kamikubo Y; Morodomi Y; Chen Y; Zarpellon A; Eberhardt J; Forli S; Fahs SA; Sood R; Haberichter SL; Montgomery RR; Ruggeri ZM
Blood Adv; 2018 Oct; 2(19):2522-2532. PubMed ID: 30287479
[TBL] [Abstract][Full Text] [Related]
26. Antidote-controlled platelet inhibition targeting von Willebrand factor with aptamers.
Oney S; Nimjee SM; Layzer J; Que-Gewirth N; Ginsburg D; Becker RC; Arepally G; Sullenger BA
Oligonucleotides; 2007; 17(3):265-74. PubMed ID: 17854267
[TBL] [Abstract][Full Text] [Related]
27. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
28. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets.
Kroner PA; Kluessendorf ML; Scott JP; Montgomery RR
Blood; 1992 Apr; 79(8):2048-55. PubMed ID: 1373334
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
30. Enhanced shear-induced platelet aggregation due to low-temperature storage.
Montgomery RK; Reddoch KM; Evani SJ; Cap AP; Ramasubramanian AK
Transfusion; 2013 Jul; 53(7):1520-30. PubMed ID: 23043289
[TBL] [Abstract][Full Text] [Related]
31. Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates.
Krupski WC; Bass A; Cadroy Y; Kelly AB; Harker LA; Hanson SR
Surgery; 1992 Aug; 112(2):433-9; discussion 439-40. PubMed ID: 1641780
[TBL] [Abstract][Full Text] [Related]
32. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.
Chen Z; Zhang J; Kareem K; Tran D; Conway RG; Arias K; Griffith BP; Wu ZJ
Artif Organs; 2019 Aug; 43(8):745-755. PubMed ID: 30805954
[TBL] [Abstract][Full Text] [Related]
33. Exploiting the kinetic interplay between GPIbα-VWF binding interfaces to regulate hemostasis and thrombosis.
Chen J; Zhou H; Diacovo A; Zheng XL; Emsley J; Diacovo TG
Blood; 2014 Dec; 124(25):3799-807. PubMed ID: 25293780
[TBL] [Abstract][Full Text] [Related]
34. [von Willebrand factor and von Willebrand disease].
Matsui T; Hamako J
Rinsho Ketsueki; 2016; 57(10):2113-2123. PubMed ID: 27795521
[TBL] [Abstract][Full Text] [Related]
35. Hemostatic effect of platelet von Willebrand factor.
Castillo R; Escolar G; Monteagudo J; Reverter JC; Ordinas A
Haemostasis; 1992; 22(5):233-5. PubMed ID: 1478532
[TBL] [Abstract][Full Text] [Related]
36. The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin.
Kovacevic KD; Buchtele N; Schoergenhofer C; Derhaschnig U; Gelbenegger G; Brostjan C; Zhu S; Gilbert JC; Jilma B
Sci Rep; 2020 Jul; 10(1):11180. PubMed ID: 32636459
[TBL] [Abstract][Full Text] [Related]
37. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets.
Nesheim M; Pittman DD; Giles AR; Fass DN; Wang JH; Slonosky D; Kaufman RJ
J Biol Chem; 1991 Sep; 266(27):17815-20. PubMed ID: 1917924
[TBL] [Abstract][Full Text] [Related]
38. [Development of a novel aptamer blocking the interaction between the VWF A1 domain and platelet GP Ib for the treatment of arterial thrombosis].
Matsumoto M; Harada K
Rinsho Ketsueki; 2022; 63(5):393-402. PubMed ID: 35662162
[TBL] [Abstract][Full Text] [Related]
39. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
[TBL] [Abstract][Full Text] [Related]
40. Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation.
Michels A; Swystun LL; Mewburn J; Albánez S; Lillicrap D
J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
